◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

MedX Health Corp

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 135,268 88,512 111,086 188,039 90,609 --
Operating Revenue 135,268 88,512 111,086 188,039 90,609 --
Cost Of Revenue 98,036 70,888 63,416 114,872 56,528 --
Gross Profit 37,233 17,625 47,670 73,167 34,081 --
Selling General And Administration 685,587 765,335 1.0M 213,832 308,990 --
General And Administrative Expense 685,587 756,998 1.0M 211,509 308,990 --
Research And Development 125,400 125,699 124,050 133,049 125,551 --
Depreciation And Amortization In Income Statement 7,858 7,858 8,001 8,253 7,576 --
Other Operating Expenses 97,109 50,582 76,004 48,113 79,015 --
Operating Expense 915,954 949,474 1.2M 403,247 521,132 --
Operating Income -878,721 -931,849 -1.2M -330,080 -487,051 --
EBIT -878,721 -931,849 -1.2M -330,080 -487,051 --
Interest Expense 404,834 383,964 395,940 775,794 206,938 --
Interest Expense Non Operating 404,834 383,964 395,940 775,794 206,938 --
Net Interest Income -404,834 -383,964 -395,940 -775,794 -206,938 --
Pretax Income -1.3M -1.3M -1.6M -1.1M -693,989 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Income From Continuing Operation Net Minority Interest -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Income Including Noncontrolling Interests -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Income Common Stockholders -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Income -1.3M -1.3M -1.6M -1.1M -693,989 --
EBITDA -865,790 -920,397 -1.2M -318,376 -475,347 --
Normalized EBITDA -865,790 -920,397 -1.2M -318,376 -475,347 --
Reconciled Depreciation 12,931 11,452 11,452 11,704 11,704 --
Basic EPS 0.00 0.00 -0.01 -- 0.00 0.00
Diluted EPS 0.00 0.00 -0.01 -- 0.00 0.00
Basic Average Shares 301.8M 290.8M 272.3M -- 270.0M 264.7M
Diluted Average Shares 301.8M 290.8M 272.3M -- 270.0M 264.7M
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -1.3M -1.3M -1.6M -1.1M -693,989 --
Amortization 7,858 7,858 8,001 8,253 7,576 --
Amortization Of Intangibles Income Statement 7,858 7,858 8,001 8,253 7,576 --
Depreciation Amortization Depletion Income Statement 7,858 7,858 8,001 8,253 7,576 --
Diluted NI Availto Com Stockholders -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Income Continuous Operations -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Non Operating Interest Income Expense -404,834 -383,964 -395,940 -775,794 -206,938 --
Other Gand A 270,854 253,405 143,298 -35,734 64,221 --
Reconciled Cost Of Revenue 92,963 67,294 59,965 111,421 52,400 --
Salaries And Wages 414,733 503,593 897,285 247,243 244,769 --
Selling And Marketing Expense -- 8,337 0.00 2,323 -116,370 3,535
Total Expenses 1.0M 1.0M 1.3M 518,119 577,660 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 25,513 126,536 11,373 158,290 154,445 --
Cash Cash Equivalents And Short Term Investments 25,513 126,536 11,373 158,290 154,445 --
Cash Financial 25,513 126,536 11,373 158,290 154,445 --
Accounts Receivable 58,537 19,788 16,938 29,541 19,683 --
Receivables 509,545 419,497 336,124 293,885 248,778 --
Inventory 397,604 413,111 398,555 376,526 405,162 --
Prepaid Assets 15,549 15,690 16,130 16,130 16,226 --
Current Assets 948,211 974,834 762,182 844,831 824,611 --
Gross PPE 514,137 425,406 425,406 425,406 425,406 --
Accumulated Depreciation -207,030 -408,992 -397,540 -386,088 -374,384 --
Net PPE 307,107 16,414 27,866 39,318 51,022 --
Total Non Current Assets 307,107 16,414 27,866 39,318 51,022 --
Total Assets 1.3M 991,248 790,048 884,149 875,633 --
Current Debt 6.9M 6.1M 6.4M 5.9M 6.3M --
Current Debt And Capital Lease Obligation 6.9M 6.1M 6.4M 5.9M 6.3M --
Accounts Payable 817,614 647,798 887,657 336,782 769,672 --
Payables 1.1M 647,798 887,657 480,837 979,689 --
Payables And Accrued Expenses 2.8M 2.5M 2.7M 2.4M 2.5M --
Current Accrued Expenses 1.7M 1.8M 1.8M 1.9M 1.5M --
Current Deferred Revenue 9,872 9,872 9,872 9,872 9,105 --
Current Liabilities 9.7M 8.6M 9.1M 8.3M 8.9M --
Long Term Debt 1.3M 1.2M 1.2M 1.1M 999,428 --
Long Term Debt And Capital Lease Obligation 1.6M 1.2M 1.2M 1.1M 996,224 --
Long Term Capital Lease Obligation 254,492 -- -- -- -3,204 9,797
Total Non Current Liabilities Net Minority Interest 1.6M 1.2M 1.2M 1.1M 996,224 --
Total Liabilities Net Minority Interest 11.3M 9.8M 10.3M 9.4M 9.8M --
Common Stock 28.9M 28.9M 27.5M 27.5M 27.3M --
Capital Stock 28.9M 28.9M 27.5M 27.5M 27.3M --
Additional Paid In Capital 15.1M 15.0M 15.0M 14.4M 12.2M --
Retained Earnings -58.7M -57.4M -56.1M -54.5M -53.4M --
Common Stock Equity -10.0M -8.8M -9.5M -8.5M -9.0M --
Stockholders Equity -10.0M -8.8M -9.5M -8.5M -9.0M --
Total Equity Gross Minority Interest -10.0M -8.8M -9.5M -8.5M -9.0M --
Total Capitalization -8.7M -7.6M -8.4M -7.4M -8.0M --
Net Tangible Assets -10.0M -8.8M -9.5M -8.5M -9.0M --
Tangible Book Value -10.0M -8.8M -9.5M -8.5M -9.0M --
Working Capital -8.8M -7.6M -8.4M -7.5M -8.0M --
Invested Capital -1.9M -1.5M -1.9M -1.5M -1.7M --
Total Debt 8.5M 7.3M 7.6M 7.0M 7.3M --
Net Debt 8.1M 7.2M 7.6M 6.8M 7.1M --
Share Issued 301.8M 301.8M 272.3M 272.3M 270.2M --
Ordinary Shares Number 301.8M 301.8M 272.3M 272.3M 270.2M --
Allowance For Doubtful Accounts Receivable -116,490 -116,490 -116,490 -116,490 -116,490 --
Capital Lease Obligations 300,044 9,796 24,189 38,229 51,922 --
Current Capital Lease Obligation 45,552 9,796 24,189 38,229 55,126 --
Current Deferred Liabilities 9,872 9,872 9,872 9,872 9,105 --
Current Notes Payable 1.2M 1.2M -- -- -- --
Dueto Related Parties Current -- -- -- -- 210,017 209,252
Finished Goods 165,864 194,087 233,623 147,688 182,876 --
Gross Accounts Receivable 175,027 136,278 133,428 146,031 136,173 --
Interest Payable 479,374 110,299 409,846 520,398 413,361 --
Machinery Furniture Equipment 155,401 155,401 155,401 155,401 155,401 --
Other Current Borrowings 5.6M 4.8M 6.4M 5.9M 6.3M --
Other Equity Interest 4.7M 4.7M 4.1M 4.1M 4.9M --
Other Inventories -- -- -- -- -1.00 --
Other Properties 358,736 270,005 270,005 270,005 270,005 --
Raw Materials 231,740 219,024 164,932 228,838 222,287 --
Taxes Receivable 451,008 399,709 319,186 264,344 229,095 --
Total Tax Payable 259,654 -- -- 144,055 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -687,646 -1.4M -487,878 -597,461 -699,049 --
Cash Flow From Continuing Operating Activities -687,647 -1.4M -487,878 -597,461 -699,049 --
Depreciation And Amortization 12,931 11,452 11,452 11,704 11,704 --
Depreciation Amortization Depletion 12,931 11,452 11,452 11,704 11,704 --
Stock Based Compensation 55,181 19,300 613,878 13,911 38,994 --
Change In Working Capital 254,282 -321,739 257,751 -133,263 -111,415 --
Changes In Account Receivables -38,749 -2,850 12,603 -9,856 3,940 --
Change In Receivables -90,048 -83,373 -42,239 -45,105 -19,627 --
Change In Inventory 15,507 -14,556 -22,029 28,636 -20,924 --
Change In Payables And Accrued Expense 328,682 -224,250 322,019 -117,657 -70,864 --
Other Non Cash Items 404,835 383,965 395,940 775,794 206,938 --
Purchase Of PPE -- -- 0.00 -- -- --
Net PPE Purchase And Sale -- -- 0.00 -- -- --
Investing Cash Flow -- -- 0.00 -- -- --
Cash Flow From Continuing Investing Activities -- -- 0.00 -- -- --
Issuance Of Debt 600,000 0.00 355,000 635,000 680,000 --
Repayment Of Debt -13,377 -22,074 -14,039 -33,694 -38,000 --
Net Issuance Payments Of Debt 586,623 -22,074 340,961 601,306 642,000 --
Issuance Of Capital Stock 0.00 1.5M -- 0.00 50,000 375,983
Net Common Stock Issuance 0.00 1.5M -- 0.00 50,000 375,983
Financing Cash Flow 586,623 1.5M 340,961 601,306 692,000 --
Cash Flow From Continuing Financing Activities 586,623 1.5M 340,961 601,306 692,000 --
Changes In Cash -101,023 115,163 -146,917 3,845 -7,049 --
Beginning Cash Position 126,536 11,373 158,290 154,445 161,494 --
End Cash Position 25,513 126,536 11,373 158,290 154,445 --
Free Cash Flow -687,646 -1.4M -487,878 -597,461 -699,049 --
Change In Prepaid Assets 141.00 440.00 0.00 96.00 0.00 --
Common Stock Issuance 0.00 1.5M -- 0.00 50,000 375,983
Depreciation 12,931 11,452 11,452 11,704 11,704 --
Interest Paid Cfo -131,320 -166,273 -169,991 -159,732 -151,281 --
Long Term Debt Issuance -- -- -- 0.00 0.00 0.00
Long Term Debt Payments -13,377 -14,393 -14,039 -13,694 -13,000 --
Net Income From Continuing Operations -1.3M -1.3M -1.6M -1.1M -693,989 --
Net Long Term Debt Issuance -13,377 -14,393 -14,039 -13,694 -13,000 --
Net Short Term Debt Issuance 600,000 -7,681 355,000 615,000 655,000 --
Proceeds From Stock Option Exercised -- -- -- 0.00 0.00 0.00
Short Term Debt Issuance 600,000 0.00 355,000 635,000 680,000 --
Short Term Debt Payments 0.00 -7,681 -- -20,000 -25,000 -4,800
NEWS
Loading news...
TRENDING
Loading...